Alvaro Moreira
The University of Texas Health Science Center at San Antonio(US)AbbVie (United States)(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Dermatology and Skin Diseases, Immune Cell Function and Interaction, CAR-T cell therapy research
Most-Cited Works
- → Immunology of COVID-19: Current State of the Science(2020)1,775 cited
- → Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors(2018)227 cited
- → Eosinophilic Count as a Biomarker for Prognosis of Melanoma Patients and Its Importance in The Response to Immunotherapy(2017)148 cited
- → Hematological immune related adverse events after treatment with immune checkpoint inhibitors(2021)86 cited
- → Vaccines for immunoprevention of cancer(2021)76 cited
- → Current Melanoma Treatments: Where Do We Stand?(2021)55 cited
- → Senescence markers: Predictive for response to checkpoint inhibitors(2018)53 cited
- → Real world experience in low-dose ipilimumab in combination with PD-1 blockade in advanced melanoma patients(2018)46 cited
- → Kawasaki disease linked to COVID-19 in children(2020)40 cited
- → Skin symptoms as diagnostic clue for autoinflammatory diseases(2017)33 cited